Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 40% ± 14% | |
peripheral blood | 17 studies | 38% ± 13% | |
intestine | 12 studies | 37% ± 14% | |
kidney | 8 studies | 35% ± 10% | |
eye | 7 studies | 31% ± 12% | |
brain | 6 studies | 27% ± 7% | |
placenta | 5 studies | 44% ± 17% | |
lymph node | 5 studies | 35% ± 9% | |
bone marrow | 4 studies | 29% ± 14% | |
uterus | 4 studies | 55% ± 12% | |
prostate | 4 studies | 23% ± 7% | |
breast | 4 studies | 42% ± 5% | |
liver | 4 studies | 33% ± 4% | |
pancreas | 3 studies | 62% ± 23% | |
skin | 3 studies | 31% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 5094.91 | 258 / 258 | 100% | 31.17 | 230 / 230 |
brain | 100% | 5189.94 | 2639 / 2642 | 100% | 18.47 | 703 / 705 |
uterus | 100% | 7441.76 | 170 / 170 | 100% | 20.00 | 457 / 459 |
ovary | 100% | 5671.36 | 180 / 180 | 100% | 17.96 | 428 / 430 |
thymus | 100% | 6034.90 | 653 / 653 | 100% | 14.65 | 602 / 605 |
esophagus | 100% | 5125.20 | 1445 / 1445 | 99% | 10.74 | 182 / 183 |
intestine | 100% | 5650.56 | 966 / 966 | 99% | 31.18 | 521 / 527 |
bladder | 100% | 5463.90 | 21 / 21 | 99% | 24.88 | 498 / 504 |
prostate | 100% | 5451.30 | 244 / 245 | 99% | 23.48 | 498 / 502 |
stomach | 100% | 4810.46 | 359 / 359 | 99% | 23.14 | 282 / 286 |
kidney | 100% | 5240.42 | 89 / 89 | 98% | 13.27 | 886 / 901 |
pancreas | 100% | 3101.69 | 328 / 328 | 98% | 24.95 | 175 / 178 |
breast | 100% | 5596.60 | 459 / 459 | 98% | 16.74 | 1097 / 1118 |
lung | 100% | 6036.82 | 577 / 578 | 98% | 14.49 | 1134 / 1155 |
skin | 100% | 5427.81 | 1808 / 1809 | 98% | 16.68 | 462 / 472 |
liver | 100% | 3455.08 | 225 / 226 | 91% | 11.45 | 371 / 406 |
adipose | 100% | 5653.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 17.16 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.59 | 29 / 29 |
spleen | 100% | 5393.90 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.69 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.61 | 1 / 1 |
blood vessel | 100% | 8858.54 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3274.00 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 5560.96 | 909 / 929 | 0% | 0 | 0 / 0 |
muscle | 96% | 2299.72 | 767 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0051020 | Molecular function | GTPase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0070064 | Molecular function | proline-rich region binding |
Gene name | RABAC1 |
Protein name | PRA1 family protein Prenylated Rab acceptor protein 1 (PRA1 family protein 1) |
Synonyms | hCG_22312 PRA1 PRAF1 |
Description | FUNCTION: General Rab protein regulator required for vesicle formation from the Golgi complex. May control vesicle docking and fusion by mediating the action of Rab GTPases to the SNARE complexes. In addition it inhibits the removal of Rab GTPases from the membrane by GDI. . |
Accessions | Q9UI14 M0QXU8 M0QXH1 ENST00000601078.5 M0R3D4 ENST00000222008.11 M0R1H9 ENST00000600292.5 ENST00000601891.5 ENST00000601028.1 |